Aurora Denver Cardiology Associates
Aurora, Colorado, United States
Cardiologist in Aurora, Colorado
1444 S Potomac St Suite 300, Aurora, CO 80012
About Aurora Denver Cardiology Associates
"Our mission is to provide comprehensive, superior-quality and cost-effective cardiovascular care."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Abbott Medical Devices
3
United Therapeutics
3
Biotronik, Inc.
2
Boehringer Ingelheim
2
Boston Scientific Corporation
2
Gilead Sciences
2
Lung Biotechnology PBC
2
Otsuka Pharmaceutical Development & Commercialization, Inc.
2
Abbott Nutrition
1
ActivBiotics
1
Akebia Therapeutics
1
Clinical Trials at Aurora Denver Cardiology Associates
During the past decade, Aurora Denver Cardiology Associates conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 11 clinical trials were completed, i.e. on
average, 157.1% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 7 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy and Safety of Azimilide in the Prophylactic Treatment of Patients With Atrial Fibrillation.
2000-12-01
2004-01-01
Completed
431
Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation (AMADEUS)
2003-09-01
2006-03-01
Completed
4,673
EVEREST: Efficacy of Vasopressin Antagonism in hEart failuRE: Outcome Study With Tolvaptan
2003-09-01
2006-07-01
Completed
3,600
"SALT Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia
2003-04-01
2006-02-01
Completed
240
To Find the Best Dose of pVGI.1(VEGF2) to Benefit Angina Patients When Given With an Experimental Injection Catheter
2004-08-01
Unknown status
404
PROVIDENCE-1: Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients
2005-11-01
2007-12-01
Unknown status
274
Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stent in the Treatment of In-Stent Restenosis
2003-06-01
2010-01-01
Completed
488
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Aurora Denver Cardiology Associates" #1 sponsor was "Abbott Medical Devices" with 3 trials, followed by "United Therapeutics" with 3 trials
sponsored, "Biotronik, Inc." with 2 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Boston Scientific Corporation"
with 2 trials sponsored. Other sponsors include 18 different institutions and
companies that sponsored additional 25 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Aurora Denver Cardiology Associates"
#1 collaborator was "Medtronic" with 2 trials as a collaborator, "Otsuka Pharmaceutical Co., Ltd." with 2 trials as a collaborator, "Aurora Denver Cardiology Associates" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were
collaborators in the rest 14 trials.
Clinical Trials Conditions at Aurora Denver Cardiology Associates
According to Clinical.Site data, the most researched conditions in "Aurora Denver Cardiology Associates" are
"Atrial Fibrillation" (6 trials), "Pulmonary Arterial Hypertension" (3 trials), "Angina Pectoris" (2 trials), "Congestive Heart Failure" (2 trials) and "Heart Failure With Preserved Ejection Fraction" (2 trials). Many other conditions were trialed in "Aurora Denver Cardiology Associates" in a lesser frequency.
Clinical Trials Intervention Types at Aurora Denver Cardiology Associates
Most popular intervention types in "Aurora Denver Cardiology Associates" are "Drug" (20 trials), "Device" (8 trials), "Dietary Supplement" (3 trials), "Other" (3 trials) and "Genetic" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Oral treprostinil" (3 trials), "Darusentan" (2 trials), "Guanfacine" (2 trials) and "AMPLATZER Septal Occluder" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Aurora Denver Cardiology Associates
The vast majority of trials in "Aurora Denver Cardiology Associates" are
34 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Aurora Denver Cardiology Associates
Currently, there are NaN active trials in "Aurora Denver Cardiology Associates".
undefined are not yet recruiting,
undefined are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 24 completed trials in Aurora Denver Cardiology Associates,
undefined suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Aurora Denver Cardiology Associates, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 20 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 4 trials, and there were
also 6 trials that are defined as “Not Applicable".